Abstract
Despite improved clinical outcomes with pancreas transplantation, infectious complications remain a significant cause of morbidity and mortality in pancreas transplant recipients. The spectrum of organisms encountered ranges from routine community-acquired and nosocomial pathogens to rare opportunists. This broad spectrum, combined with the sometimes atypical presentation and rapid progression of illness, poses a challenge to the diagnosis and management of infections in transplant recipients. Although many of the fundamentals of diagnosis, management, and prevention of infections in solid organ transplantation apply to the pancreas transplant population, there are features that are unique to pancreas transplantation. While a comprehensive review of the wide spectrum of infectious diseases encountered in pancreas transplantation is outside the scope of this text, the most salient risk factors, epidemiology, timing, clinical features, treatment, and prevention of infection specific to pancreas transplantation is reviewed in this chapter.
References
Ablorsu E, Ghazanfar A, Mehra S et al (2008) Outcome of pancreas transplantation in recipients older than 50 years: a single-centre experience. Transplantation 86(11):1511–1514. doi:10.1097/TP.0b013e3181891cd6
Afaneh C, Rich BS, Aull MJ, Hartono C, Leeser DB, Kapur S (2011) Pancreas transplantation: does age increase morbidity? J Transplant 2011:596801. doi:10.1155/2011/596801
Al-Hasan MN, Razonable RR, Eckel-Passow JE, Baddour LM (2009) Incidence rate and outcome of Gram-negative bloodstream infection in solid organ transplant recipients. Am J Transplant 9(4):835–843. doi:10.1111/j.1600-6143.2009.02559.x
Allen UD, Preiksaitis JK (2013) Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation. Am J Transplant 13(Suppl 4):107–120. doi:10.1111/ajt.12104
Asberg A, Humar A, Rollag H et al (2007) Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 7(9):2106–2113. doi:10.1111/j.1600-6143.2007.01910.x
Axelrod D, Leventhal JR, Gallon LG, Parker MA, Kaufman DB (2005) Reduction of CMV disease with steroid-free immunosuppression in simultaneous pancreas-kidney transplant recipients. Am J Transplant 5(6):1423–1429. doi:10.1111/j.1600-6143.2005.00855.x
Baddley JW, Forrest GN, The ASTIDCoP (2013) Cryptococcosis in solid organ transplantation. Am J Transplant 13(s4):242–249. doi:10.1111/ajt.12116
Bassetti M, Salvalaggio PR, Topal J et al (2004) Incidence, timing and site of infections among pancreas transplant recipients. J Hosp Infect 56(3):184–190. doi:10.1016/j.jhin.2003.11.001
Benedetti E, Gruessner AC, Troppmann C et al (1996) Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome. J Am Coll Surg 183(4):307–316
Berger N, Wirmsberger R, Kafka R et al (2006) Infectious complications following 72 consecutive enteric-drained pancreas transplants. Transplant Int 19(7):549–557. doi:10.1111/j.1432-2277.2006.00293.x
Bern C (2012) Chagas disease in the immunosuppressed host. Curr Opin Infect Dis 25(4):450–457. doi:10.1097/QCO.0b013e328354f179
Brennan DC, Legendre C, Patel D et al (2011) Cytomegalovirus incidence between everolimus versus mycophenolate in de novo renal transplants: pooled analysis of three clinical trials. Am J Transplant 11(11):2453–2462. doi:10.1111/j.1600-6143.2011.03674.x
Caillard S, Lamy FX, Quelen C et al (2012) Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas. Am J Transplant 12(3):682–693. doi:10.1111/j.1600-6143.2011.03896.x
Clancy CJ, Nguyen MH (2013) Finding the “missing 50%” of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis 56(9):1284–1292. doi:10.1093/cid/cit006
Cook K, Sollinger HW, Warner T, Kamps D, Belzer FO (1983) Pancreaticocystostomy: an alternative method for exocrine drainage of segmental pancreatic allografts. Transplantation 35(6):634–636
Danziger-Isakov L, Kumar D, The ASTIDCoP (2013) Vaccination in solid organ transplantation. Am J Transplant 13(s4):311–317. doi:10.1111/ajt.12122
de Leon EM, Jacober SJ, Sobel JD, Foxman B (2002) Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis 2:1
Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B (1997) Impaired leukocyte functions in diabetic patients. Diabet Med 14(1):29–34. doi:10.1002/(sici)1096-9136(199701)14:1<29::aid-dia300>3.0.co;2-v
Dunn DL, Najarian JS (1991) New approaches to the diagnosis, prevention, and treatment of cytomegalovirus infection after transplantation. Am J Surg 161(2):250–255
Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD (2000) Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet (London, England) 355(9220):2032–2036. doi:10.1016/s0140-6736(00)02350-3
Everett JE, Wahoff DC, Statz C et al (1994) Characterization and impact of wound infection after pancreas transplantation. Arch surg (Chicago, Ill: 1960) 129(12):1310–1316; discussion 1316–1317
Fernandez-Sabe N, Cervera C, Farinas MC et al (2012) Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: a matched case–control study. Clin Infect Dis 54(3):355–361. doi:10.1093/cid/cir806
Fischer SA, Lu K, The ASTIDCoP (2013) Screening of donor and recipient in solid organ transplantation. Am J Transplant 13(s4):9–21. doi:10.1111/ajt.12094
Fishman JA (2007) Infection in solid-organ transplant recipients. N Engl J Med 357(25):2601–2614. doi:10.1056/NEJMra064928
Fishman JA, Rubin RH (1998) Infection in organ-transplant recipients. N Engl J Med 338(24):1741–1751. doi:10.1056/nejm199806113382407
Flechner SM, Avery RK, Fisher R et al (1998) A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Transplantation 66(12):1682–1688
Fontana I, Bertocchi M, Diviacco P et al (2009) Infections after simultaneous pancreas and kidney transplantation: a single-center experience. Transplant Proc 41(4):1333–1335. doi:10.1016/j.transproceed.2009.03.085
Gelson W, Hoare M, Vowler S et al (2010) Features of immune senescence in liver transplant recipients with established grafts. Liver Transpl 16(5):577–587. doi:10.1002/lt.22033
George MJ, Snydman DR, Werner BG et al (1997) The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. Am J Med 103(2):106–113
Graham PL 3rd, Lin SX, Larson EL (2006) A U.S. population-based survey of Staphylococcus aureus colonization. Ann Intern Med 144(5):318–325
Green M (2013) Introduction: infections in solid organ transplantation. Am J Transplant 13(Suppl 4):3–8. doi:10.1111/ajt.12093
Greenberg MS, Friedman H, Cohen SG, Oh SH, Laster L, Starr S (1987) A comparative study of herpes simplex infections in renal transplant and leukemic patients. J Infect Dis 156(2):280–287
Gruessner AC, Sutherland DE (2005) Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 19(4):433–455. doi:10.1111/j.1399-0012.2005.00378.x
Gruessner AC, Sutherland DE, Gruessner RW (2010) Pancreas transplantation in the United States: a review. Curr Opin Organ Transplant 15(1):93–101. doi:10.1097/MOT.0b013e32833552d2
Herrero-Martinez JM, Lumbreras C, Manrique A et al (2013) Epidemiology, risk factors and impact on long-term pancreatic function of infection following pancreas-kidney transplantation. Clin Microbiol Infect 19(12):1132–1139. doi:10.1111/1469-0691.12165
Hesse UJ, Sutherland DE, Simmons RL, Najarian JS (1986) Intra-abdominal infections in pancreas transplant recipients. Ann Surg 203(2):153–162
Humar A, Snydman D (2009) Cytomegalovirus in solid organ transplant recipients. Am J Transplant 9(Suppl 4):S78–S86. doi:10.1111/j.1600-6143.2009.02897.x
Husain S, Wagener MM, Singh N (2001) Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis 7(3):375–381. doi:10.3201/eid0703.010302
Issa N, Amer H, Dean PG et al (2009) Posttransplant lymphoproliferative disorder following pancreas transplantation. Am J Transplant 9(8):1894–1902. doi:10.1111/j.1600-6143.2009.02691.x
Kalil AC, Levitsky J, Lyden E, Stoner J, Freifeld AG (2005) Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med 143(12):870–880
Kim RD, Oreopoulos DG, Qiu K et al (2005) Impact of mode of dialysis on intra-abdominal infection after simultaneous pancreas-kidney transplantation. Transplantation 80(3):339–343
Kotton CN (2007) Zoonoses in solid-organ and hematopoietic stem cell transplant recipients. Clin Infect Dis 44(6):857–866. doi:10.1086/511859
Kumar D, Welsh B, Siegal D, Chen MH, Humar A (2007) Immunogenicity of pneumococcal vaccine in renal transplant recipients – three year follow-up of a randomized trial. Am J Transplant 7(3):633–638. doi:10.1111/j.1600-6143.2007.01668.x
Lapchik MS, Castelo Filho A, Pestana JO, Silva Filho AP, Wey SB (1992) Risk factors for nosocomial urinary tract and postoperative wound infections in renal transplant patients: a matched-pair case–control study. J Urol 147(4):994–998
Lebbe C, Porcher R, Marcelin AG et al (2013) Human herpesvirus 8 (HHV8) transmission and related morbidity in organ recipients. Am J Transplant 13(1):207–213. doi:10.1111/j.1600-6143.2012.04290.x
Linhares MM, Gonzalez AM, Trivino T et al (2004) Simultaneous pancreas-kidney transplantation: infectious complications and microbiological aspects. Transplant Proc 36(4):980–981. doi:10.1016/j.transproceed.2004.03.114
Lumbreras C, Fernandez I, Velosa J, Munn S, Sterioff S, Paya CV (1995) Infectious complications following pancreatic transplantation: incidence, microbiological and clinical characteristics, and outcome. Clin Infect Dis 20(3):514–520
Marik PE (2006) Fungal infections in solid organ transplantation. Expert Opin Pharmacother 7(3):297–305. doi:10.1517/14656566.7.3.297
Martin SI, Fishman JA, The ASTIDCoP (2013) Pneumocystis pneumonia in solid organ transplantation. Am J Transplant 13(s4):272–279. doi:10.1111/ajt.12119
Mejia R, Nutman TB (2012) Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr Opin Infect Dis 25(4):458–463. doi:10.1097/QCO.0b013e3283551dbd
Mezochow AK, Henry R, Blumberg EA, Kotton CN (2015) Transfusion transmitted infections in solid organ transplantation. Am J Transplant 15(2):547–554. doi:10.1111/ajt.13006
Michalak G, Kwiatkowski A, Bieniasz M et al (2005) Infectious complications after simultaneous pancreas-kidney transplantation. Transplant Proc 37(8):3560–3563. doi:10.1016/j.transproceed.2005.09.078
Miller R, Assi M, The ASTIDCoP (2013) Endemic fungal infections in solid organ transplantation. Am J Transplant 13(s4):250–261. doi:10.1111/ajt.12117
Miro JM, Ricart MJ, Trullas JC et al (2010) Simultaneous pancreas-kidney transplantation in HIV-infected patients: a case report and literature review. Transplant Proc 42(9):3887–3891. doi:10.1016/j.transproceed.2010.09.003
Munoz-Price LS, Slifkin M, Ruthazer R et al (2004) The clinical impact of ganciclovir prophylaxis on the occurrence of bacteremia in orthotopic liver transplant recipients. Clin Infect Dis 39(9):1293–1299. doi:10.1086/425002
Nicol DL, P’Ng K, Hardie DR, Wall DR, Hardie IR (1993) Routine use of indwelling ureteral stents in renal transplantation. J Urol 150(5 Pt 1):1375–1379
Ojo AO, Meier-Kriesche HU, Arndorfer JA et al (2001) Long-term benefit of kidney-pancreas transplants in type 1 diabetics. Transplant Proc 33(1–2):1670–1672
Ostrosky-Zeichner L, Alexander BD, Kett DH et al (2005) Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 41(5):654–659. doi:10.1086/432470
Padillo-Ruiz J, Arjona-Sanchez A, Munoz-Casares C, Ruiz-Rabelo J, Navarro MD, Regueiro JC (2010) Impact of peritoneal dialysis versus hemodialysis on incidence of intra-abdominal infection after simultaneous pancreas-kidney transplant. World J Surg 34(7):1684–1688. doi:10.1007/s00268-010-0527-z
Pappas PG, Alexander BD, Andes DR et al (2010) Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 50(8):1101–1111. doi:10.1086/651262
Pappas PG, Kauffman CA, Andes DR et al (2016) Executive summary: clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 62(4):409–417. doi:10.1093/cid/civ1194
Paraskevas S, Coad JE, Gruessner A et al (2005) Posttransplant lymphoproliferative disorder in pancreas transplantation: a single-center experience. Transplantation 80(5):613–622
Parsaik AK, Bhalla T, Dong M et al (2011) Epidemiology of cytomegalovirus infection after pancreas transplantation. Transplantation 92(9):1044–1050. doi:10.1097/TP.0b013e31823015c1
Patel G, Arvelakis A, Sauter BV, Gondolesi GE, Caplivski D, Huprikar S (2008) Strongyloides hyperinfection syndrome after intestinal transplantation. Transplant Infect Dis 10(2):137–141. doi:10.1111/j.1399-3062.2007.00256.x
Paya CV (1993) Fungal infections in solid-organ transplantation. Clin Infect Dis 16(5):677–688
Paya CV, Fung JJ, Nalesnik MA et al (1999) Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation 68(10):1517–1525
Perfect JR, Dismukes WE, Dromer F et al (2010) Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis 50(3):291–322. doi:10.1086/649858
Pergam SA, Limaye AP, The ASTIDCoP (2013) Varicella zoster virus in solid organ transplantation. Am J Transplant 13(s4):138–146. doi:10.1111/ajt.12107
Portela D, Patel R, Larson-Keller JJ et al (1995) OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation. J Infect Dis 171(4):1014–1018
Preiksaitis JK (2004) New developments in the diagnosis and management of posttransplantation lymphoproliferative disorders in solid organ transplant recipients. Clin Infect Dis 39(7):1016–1023. doi:10.1086/424447
Preiksaitis JK, Keay S (2001) Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients. Clin Infect Dis 33(Suppl 1):S38–S46. doi:10.1086/320903
Razonable RR, Humar A (2013) Cytomegalovirus in solid organ transplantation. Am J Transplant 13(Suppl 4):93–106. doi:10.1111/ajt.12103
Rodriguez M, Fishman JA (2004) Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients. Clin Microbiol Rev 17(4):770–782. doi:10.1128/cmr.17.4.770-782.2004, table of contents
Rostambeigi N, Kudva YC, John S et al (2010) Epidemiology of infections requiring hospitalization during long-term follow-up of pancreas transplantation. Transplantation 89(9):1126–1133. doi:10.1097/TP.0b013e3181d54bb9
Rubin RH (1989) The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. JAMA 261(24):3607–3609
Rubin RH, Kemmerly SA, Conti D et al (2000) Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis. Transpl Infect Dis 2(3):112–117
Schenker P, Vonend O, Kruger B et al (2011) Long-term results of pancreas transplantation in patients older than 50 years. Transpl Int 24(2):136–142. doi:10.1111/j.1432-2277.2010.01172.x
Schwartz BS, Mawhorter SD, The ASTIDCoP (2013) Parasitic infections in solid organ transplantation. Am J Transplant 13(s4):280–303. doi:10.1111/ajt.12120
Silveira FP, Kusne S, The ASTIDCoP (2013) Candida infections in solid organ transplantation. Am J Transplant 13(s4):220–227. doi:10.1111/ajt.12114
Singh RP, Farney AC, Rogers J et al (2008) Analysis of bacteremia after pancreatic transplantation with enteric drainage. Transplant Proc 40(2):506–509. doi:10.1016/j.transproceed.2008.02.015
Singh NM, Husain S, The ASTIDCoP (2013) Aspergillosis in solid organ transplantation. Am J Transplant 13(s4):228–241. doi:10.1111/ajt.12115
Smets YF, van der Pijl JW, van Dissel JT, Ringers J, de Fijter JW, Lemkes HH (1997) Infectious disease complications of simultaneous pancreas kidney transplantation. Nephrol Dial Transplant 12(4):764–771
Smith JL, Corry RJ, Cooper JL, Abecassis MM (1992) Systemic (nonurinary tract) sepsis in 102 consecutive whole-organ pancreas transplants. Transplant Proc 24(3):833–834
Sollinger HW, Knechtle SJ, Reed A et al (1991) Experience with 100 consecutive simultaneous kidney-pancreas transplants with bladder drainage. Ann Surg 214(6):703–711
Sollinger HW, Odorico JS, Knechtle SJ, D’Alessandro AM, Kalayoglu M, Pirsch JD (1998) Experience with 500 simultaneous pancreas-kidney transplants. Ann Surg 228(3):284–296
Thomas MC, Mathew TH, Russ GR, Rao MM, Moran J (2001) Early peri-operative glycaemic control and allograft rejection in patients with diabetes mellitus: a pilot study. Transplantation 72(7):1321–1324
Tolkoff-Rubin NE, Cosimi AB, Russell PS, Rubin RH (1982) A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients. Rev Infect Dis 4(2):614–618
Walker RC, Marshall WF, Strickler JG et al (1995) Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis 20(5):1346–1353
Wilck MB, Zuckerman RA, The ASTIDCoP (2013) Herpes simplex virus in solid organ transplantation. Am J Transplant 13(s4):121–127. doi:10.1111/ajt.12105
Winston DJ, Wirin D, Shaked A, Busuttil RW (1995) Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients. Lancet (London, England) 346(8967):69–74
Wiseman AC (2009) Simultaneous pancreas kidney transplantation: a critical appraisal of the risks and benefits compared with other treatment alternatives. Adv Chronic Kidney Dis 16(4):278–287. doi:10.1053/j.ackd.2009.04.001
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing AG
About this entry
Cite this entry
Desai, A., Boruchoff, S.E. (2016). Infectious Issues After Pancreas Transplant. In: Lim, J. (eds) Contemporary Pancreas Transplantation. Organ and Tissue Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-20789-6_8-2
Download citation
DOI: https://doi.org/10.1007/978-3-319-20789-6_8-2
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Online ISBN: 978-3-319-20789-6
eBook Packages: Springer Reference MedicineReference Module Medicine
Publish with us
Chapter history
-
Latest
Infectious Issues After Pancreas Transplant- Published:
- 28 September 2016
DOI: https://doi.org/10.1007/978-3-319-20789-6_8-2
-
Original
Infectious Issues After Pancreas Transplant- Published:
- 10 June 2016
DOI: https://doi.org/10.1007/978-3-319-20789-6_8-1